Epigenomic inactivation of RasGAPs activates RAS signaling in a subset of luminal B breast cancers

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Invasion and metastasis of a subset of aggressive luminal B breast cancers is driven by the concomitant inactivation of the RasGAPs DAB2IP and RASAL2. Inactivation of both proteins increases RAS activity and drives invasion, whereas inactivation of DAB2IP specifically promotes NF-κB-mediated epithelial-mesenchymal transition.

Original languageEnglish (US)
Pages (from-to)131-133
Number of pages3
JournalCancer discovery
Volume7
Issue number2
DOIs
StatePublished - Feb 2017

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Epigenomic inactivation of RasGAPs activates RAS signaling in a subset of luminal B breast cancers'. Together they form a unique fingerprint.

  • Cite this